Undergrads – Lab experience: two weeks to one semester

Posted on Updated on

This opportunity is currently [CLOSED]

If you are an undergraduate who is enrolled at ASU and would like to get exposure to lab research-in-action, apply for a position as an Undergraduate Mentee (UGM). Accepted applicants will be partnered with a knowledgeable lab member (mentor) and will shadow their mentor’s research at the bench. UGM’s who are highly engaged may be invited to help analyze data or even set up and run experiments in molecular cloning, cell culture, gene editing, protein engineering, PCR, etc. depending upon the mentor’s current project. UGM’s may participate for as little as two consecutive weeks or as long as one full semester. Read the rest of this entry »

Masters – Masters Thesis Fellows Fall 2017

Posted on Updated on

The Haynes Lab at ASU is seeking Masters Thesis Fellows in the area of synthetic and systems biology for mammalian epigenetic engineering. Masters level training in the Haynes Lab will help you to develop expertise in skills that are highly attractive to the biomedical engineering and biotechnology industry: molecular cloning and DNA design; cancer molecular biology; mammalian cell culture, engineering, and analysis; protein engineering; CRISPR/Cas9 applications; and/or bioinformatics. Read the rest of this entry »

Dr. Haynes to Present at Lawrence University’s Recent Advances in Biology

Posted on

Dr. Haynes was invited to present her research in the seminar series Recent Advances in Biology hosted by the Biology Department at Lawrence University in Appleton, Wisconsin. The organizers of Recent Advances in Biology invite select speakers from other Universities to addresses issues and advances in biological research. The presentations expose students to the latest discoveries in a wide range of biological disciplines. Dr. Haynes will present a talk on engineering proteins to control gene expression in cancer cells on Monday, April 10.

Postdoc – Postdoctoral Research Fellow 2017 Search

Posted on Updated on

The Haynes Lab at ASU is seeking applicants for a Postdoctoral Researcher position in the area of synthetic and systems biology for mammalian epigenetic engineering. Required qualifications include a doctorate (PhD) in molecular cell biology,  bioengineering, biomedical engineering or a related field, and demonstrated evidence of research capability and commitment to mentoring excellence. Start date: August 2017 – January 2018. Please send a cover letter and cv to karmella.haynes@asu.edu.

Haynes Lab members to present research at Northwestern University

Posted on Updated on

Haynes lab PhD students Cassandra Barrett, Rene Daer, and Daniel Vargas will present their research during a poster session at Northwestern University, Evanston, IL for a retreat organized by the Engineering Biology Research Consortium (EBRC). The retreat will take place Friday March 24 – Saturday March 25.

EBRC is an organization where leading scientists in synthetic biology conduct collaborative research and roadmap the development of this rapidly evolving field. Members include top Universities from across the USA. Dr. Haynes is a member of the Board of Directors. Rene Daer is president of the student and postdoc association.

News: Karmella Haynes Publishes Paper on Custom-Built, Therapeutic Proteins For Cancer Treatment

Posted on Updated on

P. Zrioka, 01.13.17, ASU In The Loop: Recent findings from Assistant Professor of biomedical engineering Karmella Haynes may chart a new course in cancer treatment with the use of custom-built, therapeutic proteins. The work, published January 9 in the Nature Partner Journal Genomic Medicine, details how Haynes and her co-authors engineered proteins that activate anti-cancer genes in cancer cells.”

Read more at In The Loop.

News: Synthetic Biology And Cancer Treatment: Bottlenecks To Translation

Posted on Updated on

global_engage_logoL. Berry, 11.16.16, Global Engage. Karmella Haynes, at the Arizona State University, is one of the first synthetic biologists to engineer chromatin. It is a development that could ultimately treat diseases like cancer, through enabling large-scale changes in gene expression.

Read more at Global Engage.